QUOIN PHARMACEUTICALS, LTD. |
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 0.58 USD | -1.69% |
|
-5.29% | -88.18% |
Chart calendar Quoin Pharmaceuticals, Ltd.
d03345b7519.6hTFTOvo4Sl8eZpJRB2moVsuKYEwjAap_ICU23tWWlM.hmaPCLOygkgKKddkJX_FjGxAYfV0w2fYmu7-hDgcKBG5brcomqa5eUs_6Q~a72c07b3697054a5549e6b309fd904f4
Upcoming events on Quoin Pharmaceuticals, Ltd.
Past events on Quoin Pharmaceuticals, Ltd.
| 09/05/2024 13:30 | Q1 2024 Earnings Release |
| 29/03/2024 16:00 | Extraordinary Shareholders Meeting |
| 14/03/2024 12:30 | Q4 2023 Earnings Call |
| 13/03/2024 20:05 | Q4 2023 Earnings Release |
| 09/11/2023 13:30 | Q3 2023 Earnings Call |
| 08/11/2023 22:46 | Q3 2023 Earnings Release |
| 12/09/2023 05:00 | H.C. Wainwright Global Investment Conference |
| 03/08/2023 13:30 | Q2 2023 Earnings Call |
| 02/08/2023 21:45 | Q2 2023 Earnings Release |
| 20/06/2023 21:00 | Maxim Group Virtual Healthcare Conference |
| 09/05/2023 13:30 | Q1 2023 Earnings Call |
| 08/05/2023 22:00 | Q1 2023 Earnings Release |
| 09/03/2023 13:30 | Q4 2022 Earnings Call |
| 08/03/2023 22:08 | Q4 2022 Earnings Release |
| 10/11/2022 15:00 | Q3 2022 Earnings Call |
| 10/11/2022 13:30 | Q3 2022 Earnings Release |
| 18/08/2022 13:30 | Interim 2022 Earnings Call |
| 18/08/2022 12:00 | Interim 2022 Earnings Release |
Annual results
| Fiscal Period | December | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|---|
|
Net sales Million USD | Released Forecast Spread | 0,00 | 0,00 0,00 - | 0,00 0,00 - | 0,00 0,00 - | 0,00 |
|
EBITDA | Released Forecast Spread | 0,00 | 0,00 0,00 - | 0,00 0,00 - | 0,00 0,00 - | 0,00 |
|
EBIT Million USD | Released Forecast Spread | 0,00 | -6,06 -6,52 6.98% | -9,26 -9,43 1.8% | -9,38 -9,52 1.49% | -10,1 |
|
Earnings before Tax (EBT) Million USD | Released Forecast Spread | 0,00 | -21,5 -22,8 5.68% | -9,38 -9,75 3.8% | -8,69 -8,87 2.01% | -10,5 |
|
Net income Million USD | Released Forecast Spread | -2,10 | -21,5 -19,7 -8.99% | -9,45 -9,82 3.82% | -8,69 -8,92 2.62% | -7,98 |
|
EPS USD | Released Forecast Spread | -315 | -813 -730 -11.45% | -46,8 -55,2 15.14% | -9,64 -9,47 -1.8% | -3,52 |
| Announcement Date | 16/06/21 | 14/04/22 | 09/03/23 | 13/03/24 | - |
Quarterly results
| Fiscal Period | December | 2022 Q1 | 2022 Q2 | 2022 Q3 | 2022 Q4 | 2023 Q1 | 2023 Q2 | 2023 Q3 | 2023 Q4 | 2024 Q1 | 2024 Q2 | 2024 Q3 | 2024 Q4 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
Net sales Million USD | Released Forecast Spread | 0,00 0,00 - | 0,00 0,00 - | 0,00 0,00 - | 0,00 0,00 - | 0,00 0,00 - | 0,00 0,00 - | 0,00 0,00 - | 0,00 0,00 - | 0,00 0,00 - | 0,00 | 0,00 | 0,00 |
|
EBIT Million USD | Released Forecast Spread | -2,18 -2,19 0.55% | -2,67 -2,95 9.58% | -2,33 -2,83 17.79% | -2,09 -2,62 20.31% | -2,78 -2,97 6.48% | -2,26 -2,93 22.91% | -2,13 -2,70 21.42% | -2,22 -2,36 6.02% | -2,51 | -2,56 | -2,59 | |
|
Earnings before Tax (EBT) Million USD | Released Forecast Spread | -1,68 -1,72 1.91% | -2,67 -2,45 -8.82% | -3,03 -2,91 -4.07% | -2,00 -2,44 17.96% | -2,60 -3,03 14.09% | -2,11 -3,00 29.85% | -1,93 -2,87 32.88% | -2,05 -2,23 7.99% | -2,58 | -2,71 | -2,85 | |
|
Net income Million USD | Released Forecast Spread | -1,68 -2,29 26.45% | -2,67 -3,10 13.96% | -3,09 -2,83 -9.31% | -2,00 -2,62 23.56% | -2,60 -3,03 14.09% | -2,11 -2,95 28.63% | -1,93 -2,70 28.77% | -2,05 -2,28 10.23% | -2,46 | -2,51 | -2,57 | |
|
EPS USD | Released Forecast Spread | -30,0 -40,5 25.93% | -38,9 -33,1 -17.5% | -11,3 -16,2 30.27% | -4,95 -7,15 30.72% | -4,08 -3,12 -30.77% | -2,13 -2,92 27.05% | -1,95 -2,72 28.4% | -2,08 -2,32 10.15% | -0,72 | -0,64 | -0,65 | |
| Announcement Date | 23/05/22 | 18/08/22 | 10/11/22 | 09/03/23 | 09/05/23 | 03/08/23 | 09/11/23 | 13/03/24 | 09/05/24 | - | - | - |
| 15/07/2024 06:45 | ADDLIFE AB: Q2 2024 Earnings Release |
| 21/07/2024 | MEDPACE HOLDINGS, INC.: Q2 2024 Earnings Release |
| 23/07/2024 | SYNGENE INTERNATIONAL LIMITED: Q1 2025 Earnings Release (Projected) |
| 23/07/2024 | ALKERMES PLC: Q2 2024 Earnings Release (Projected) |
| 23/07/2024 | IQVIA HOLDINGS INC.: Q2 2024 Earnings Release (Projected) |
| 23/07/2024 | ICON PUBLIC LIMITED COMPANY: Q2 2024 Earnings Release (Projected) |
| 24/07/2024 | LONZA GROUP AG: Q2 2024 Earnings Release |
| 25/07/2024 06:00 | BACHEM HOLDING AG: Q2 2024 Earnings Release |
| 25/07/2024 | PHARVARIS N.V.: Q2 2024 Earnings Release (Projected) |
| 26/07/2024 06:00 | BB BIOTECH AG: Q2 2024 Earnings Release |
Past sector events for Quoin Pharmaceuticals, Ltd.
| 07/06/2024 07:57 | POLARIS GROUP: May 2024 Sales and Revenue Release |
| 29/05/2024 21:01 | IMMUNOVANT, INC.: Q4 2024 Earnings Release |
| 23/05/2024 12:00 | CUREVAC N.V.: Q1 2024 Earnings Release |
| 22/05/2024 06:00 | EVOTEC SE: Q1 2024 Earnings Release |
| 21/05/2024 22:14 | ALVOTECH: Q1 2024 Earnings Release |
| 21/05/2024 12:00 | EXSCIENTIA PLC: Q1 2024 Earnings Release |
| 17/05/2024 07:00 | BIOARCTIC AB: Q1 2024 Earnings Release |
| 15/05/2024 21:05 | CULLINAN THERAPEUTICS, INC.: Q1 2024 Earnings Release |
| 15/05/2024 12:00 | PERSPECTIVE THERAPEUTICS, INC.: Q1 2024 Earnings Release |
| 14/05/2024 | GNI GROUP LTD.: Q1 2024 Earnings Release |
Net sales - Quarter - Rate of surprise
Quarterly earnings - Rate of surprise
Net sales - Annual - Rate of surprise
Annual profits - Rate of surprise
- Stock Market
- Equities
- QNRX Stock
- Calendar Quoin Pharmaceuticals, Ltd.
